Glaxo Singled Out in China Probe, Smith Says

REPLAY VIDEO
Your next video will start in
Pause

Recommended Videos

  • Info

  • Comments

July 24 (Bloomberg) -- Andy Smith, chief investment officer at Mann Bioinvest Ltd., talks about the Chinese probe of GlaxoSmithKline Plc over allegations of bribery and corruption. He speaks with Mark Barton and Anna Edwards on Bloomberg Television's "Countdown." (Source: Bloomberg)

Advertisement

BTV Channel Finder

Channel_finder_loader

ZIP is required for U.S. locations

Bloomberg Television in   change